Entarica 0.5 Tablet
Marketer
Fibrica Healthcare Pvt Ltd
Salt Composition
Entecavir (0.5mg)
Overview Entarica 0.5 Tablet
Hepatitis B virus (HBV) infection is treated with the antiviral medication entecavir. Its mechanism involves hindering viral replication, thus lowering the viral load and slowing liver damage progression. Entarica 0.5mg tablets should be ingested on an empty stomach, precisely as your physician directs, ensuring consistent dosing for optimal efficacy. Regular use improves liver health and minimizes HBV-related complications. However, Entarica 0.5mg's impact on cirrhosis or hepatocellular carcinoma risk reduction remains uncertain. Continuous use, as prescribed, is crucial. Headache, nausea, vomiting, abdominal discomfort, tiredness, and diarrhea are common, typically mild, side effects; report any persistent or bothersome symptoms. Rarely, skin reactions or liver injury can occur, necessitating close monitoring, especially initially. Disclose pre-existing skin conditions or kidney disease before commencing treatment. Regular blood tests to assess liver function and blood cell counts will be required. Alcohol consumption should be avoided to prevent further liver harm. Pregnant or lactating individuals must consult their doctor. Individuals with HIV should practice safe sex, avoiding unprotected intercourse and sharing personal items to minimize HIV transmission risk.
Primary Ingredients of Entarica 0.5 Tablet
No text provided to rephrase.
Uses of Entarica 0.5 Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Entarica 0.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Entarica 0.5mg tablets should be taken on an empty stomach.
Common Side effects of Entarica 0.5 Tablet:
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Entarica 0.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Entarica 0.5 Tablet on an empty stomach.
How Entarica 0.5 Tablet works:
Each Entarica 0.5mg tablet contains an antiviral agent that inhibits viral replication within human cells. This action halts further viral production, thereby resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Entarica 0.5 Tablet may pose unknown safety risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Entarica 0.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Entarica 0.5 Tablet are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Entarica 0.5 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Entarica 0.5mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may safely use Entarica 0.5 Tablet without requiring a dosage change.
What if you forget to take Entarica 0.5 Tablet :
Should you forget to take your Entarica 0.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Entarica 0.5 Tablet
| Label | Value |
|---|---|
| Chemical Type | Analogous nucleoside |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Reverse transcriptase inhibitors (NRTIs) – nucleoside/nucleotide analogs |






